Skip to content
Home/Companies/MedTech/SimSen Diagnostics

SimSen Diagnostics

MedTech·Sweden·Active·6yr hold
Entry
2020
Hold
6yr
Status
Active

Who owns SimSen Diagnostics?

SimSen Diagnostics is currently owned by GU Ventures through GU Ventures Evergreen (1995 vintage), since 2020.

Hand-verified · updated 2026-08-17

GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorMedTech
StatusActive

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
Hydroc Energy Storage
Active
EnergySweden· 2019
Sobrera Pharma
Active
PharmaSweden· 2019

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Biocomposites
Biocomposites
Active
TA AssociatesUS
CMR Surgical
CMR Surgical
Active
LightrockUK
Neuromod Devices
Neuromod Devices
Active
Enterprise IrelandIreland
Optos
Exited 2015
Amadeus Capital PartnersUK
to
Ardos
Active
Delphinus Venture CapitalDenmark· 2026
Axomove
Axomove
Active
Go CapitalFrance· 2026
Track SimSen Diagnostics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy SimSen Diagnostics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on SimSen Diagnostics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue